MYC and prostate cancer: Working with prostate cancer and Burkitt lymphoma cells, Phang’s team demonstrated that c-Myc triggers downregulation of the PRODH1 enzyme through increased expression of Mir-23b*, while enhancing transcription from the PYCR1 and ALDH18A1 (encoding P5CS) genes95.